ZLD 12.5% 28.0¢ zelira therapeutics limited

Ann: Director Performance Rights, page-4

  1. 1,316 Posts.
    lightbulb Created with Sketch. 488
    The shares are no use until they start generating revenues in the US.

    Performance does not include any revenue to date its from 2020 july

    basically unless the US team pulls some of these licencing deals out there bum ... no cash ... no shares

    and we all agree how transformative US licencing deals will be for zelira as it prooves US licencing footprint ontop of global launch strategies

    bottom line the shares align with investor interests.

 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
-0.040(12.5%)
Mkt cap ! $3.177M
Open High Low Value Volume
32.0¢ 32.0¢ 28.0¢ $4.691K 15.43K

Buyers (Bids)

No. Vol. Price($)
1 10000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 833 1
View Market Depth
Last trade - 15.58pm 28/06/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.